Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor.

PubWeight™: 8.12‹?› | Rank: Top 0.1%

🔗 View Article (PMC 1630421)

Published in EMBO J on October 12, 2006

Authors

Pablo Pelegrin1, Annmarie Surprenant

Author Affiliations

1: Department of Biomedical Science, University of Sheffield, Sheffield, UK.

Articles citing this

(truncated to the top 100)

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol (2008) 16.65

Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol (2009) 7.80

The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ (2007) 7.74

NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol (2010) 5.90

Activation and regulation of the inflammasomes. Nat Rev Immunol (2013) 5.71

Sensing and reacting to microbes through the inflammasomes. Nat Immunol (2012) 5.24

The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol (2009) 5.21

K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity (2013) 3.96

Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe (2009) 3.86

Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol (2009) 3.85

Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev (2009) 3.20

The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem (2009) 2.90

Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Cell Physiol (2008) 2.79

Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol (2007) 2.73

A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity (2009) 2.59

Inflammasomes: too big to miss. J Clin Invest (2009) 2.51

P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol (2008) 2.49

Pannexin 1: the molecular substrate of astrocyte "hemichannels". J Neurosci (2009) 2.48

NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol (2008) 2.45

Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J Pharmacol Exp Ther (2008) 2.42

NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J Neurosci (2010) 2.41

NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog (2009) 2.31

A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol (2009) 2.29

Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev (2011) 2.14

A cation counterflux supports lysosomal acidification. J Cell Biol (2010) 2.02

ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear. Proc Natl Acad Sci U S A (2008) 2.01

Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol (2009) 1.91

NALP inflammasomes: a central role in innate immunity. Semin Immunopathol (2007) 1.91

Inflammasomes: current understanding and open questions. Cell Mol Life Sci (2010) 1.87

Connexin and pannexin mediated cell-cell communication. Neuron Glia Biol (2007) 1.86

A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. Am J Physiol Cell Physiol (2008) 1.86

Pannexin channels are not gap junction hemichannels. Channels (Austin) (2011) 1.84

Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. Am J Physiol Heart Circ Physiol (2010) 1.81

The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol (2009) 1.81

ATP release from non-excitable cells. Purinergic Signal (2009) 1.78

Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J (2009) 1.78

Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br J Pharmacol (2007) 1.77

Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science (2014) 1.77

Rho signaling regulates pannexin 1-mediated ATP release from airway epithelia. J Biol Chem (2011) 1.76

Endoplasmic Reticulum Stress Activates the Inflammasome via NLRP3- and Caspase-2-Driven Mitochondrial Damage. Immunity (2015) 1.74

NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J Leukoc Biol (2007) 1.73

Lens gap junctions in growth, differentiation, and homeostasis. Physiol Rev (2010) 1.70

Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J (2009) 1.70

Neuromodulation by extracellular ATP and P2X receptors in the CNS. Neuron (2012) 1.70

Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab (2009) 1.69

Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock. Immunity (2015) 1.61

Mechanisms of glutamate release from astrocytes. Neurochem Int (2007) 1.59

Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder. J Physiol (2015) 1.59

The P2X7 receptor channel pore dilates under physiological ion conditions. J Gen Physiol (2008) 1.57

Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol (2009) 1.56

Pannexins in ischemia-induced neurodegeneration. Proc Natl Acad Sci U S A (2011) 1.55

P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. J Neurosci (2010) 1.55

Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin Immunopathol (2007) 1.54

A molecular signature in the pannexin1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells. Sci Signal (2015) 1.53

Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading. J Biol Chem (2008) 1.52

ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem (2011) 1.52

Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes. J Leukoc Biol (2013) 1.51

Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal (2012) 1.49

The inflammasomes. PLoS Pathog (2009) 1.48

Glycosylation regulates pannexin intermixing and cellular localization. Mol Biol Cell (2009) 1.45

Connexins, pannexins, innexins: novel roles of "hemi-channels". Pflugers Arch (2008) 1.45

Inflammasomes in the CNS. Nat Rev Neurosci (2014) 1.44

Targeting pannexin1 improves seizure outcome. PLoS One (2011) 1.43

Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. J Leukoc Biol (2009) 1.40

An Improved Method for P2X7R Antagonist Screening. PLoS One (2015) 1.40

Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol (2009) 1.39

Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med (2009) 1.36

P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. J Cell Biol (2008) 1.34

Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids. Br J Pharmacol (2007) 1.34

Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid Redox Signal (2009) 1.34

Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol (2012) 1.34

Intercellular Ca(2+) waves: mechanisms and function. Physiol Rev (2012) 1.32

Fungal zymosan and mannan activate the cryopyrin inflammasome. J Biol Chem (2009) 1.32

The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta release. Purinergic Signal (2009) 1.32

Irritating channels: the case of TRPA1. J Physiol (2010) 1.32

Molecular and functional properties of P2X receptors--recent progress and persisting challenges. Purinergic Signal (2012) 1.31

P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J (2010) 1.31

Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels. J Neurosci (2010) 1.31

From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma. Curr Eye Res (2013) 1.31

Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential. Proc Natl Acad Sci U S A (2007) 1.30

Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc Natl Acad Sci U S A (2009) 1.30

A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J Biol Chem (2009) 1.29

P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest (2011) 1.29

Inflammasomes in intestinal inflammation and cancer. Gastroenterology (2011) 1.28

Patch-clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels. Proc Natl Acad Sci U S A (2008) 1.28

Paracrine signaling through plasma membrane hemichannels. Biochim Biophys Acta (2012) 1.28

Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of rho- and Ca2+-dependent signaling pathways. J Biol Chem (2009) 1.27

Analysis of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent immune cells. J Biol Chem (2009) 1.26

Divalent cations regulate connexin hemichannels by modulating intrinsic voltage-dependent gating. J Gen Physiol (2008) 1.26

Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J Neurosci (2010) 1.25

The role of the inflammasome in cellular responses to toxins and bacterial effectors. Semin Immunopathol (2007) 1.25

P2X(7): a growth-promoting receptor-implications for cancer. Purinergic Signal (2009) 1.24

Pannexin: from discovery to bedside in 11±4 years? Brain Res (2012) 1.24

Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal (2010) 1.24

Extrinsic and intrinsic control of macrophage inflammatory responses. J Leukoc Biol (2013) 1.23

Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors. J Leukoc Biol (2010) 1.22

ATP signaling is deficient in cultured Pannexin1-null mouse astrocytes. Glia (2012) 1.22

The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J Clin Invest (2011) 1.21

Pannexin1 regulates α1-adrenergic receptor- mediated vasoconstriction. Circ Res (2011) 1.21

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43

Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74

Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature (2004) 14.80

Molecular physiology of P2X receptors. Physiol Rev (2002) 13.61

Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 10.58

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature (2006) 9.77

Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell (2004) 6.06

Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem (2001) 5.74

The P2X7 receptor: a key player in IL-1 processing and release. J Immunol (2006) 5.35

Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett (2004) 4.73

Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity (2001) 4.23

Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem (1994) 4.17

Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci U S A (2006) 4.03

Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res (1997) 3.98

Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett (2005) 3.89

Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem (2005) 3.87

Blocking IL-1 in systemic inflammation. J Exp Med (2005) 3.37

P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling. J Neurosci (2006) 3.14

Ischemia opens neuronal gap junction hemichannels. Science (2006) 3.00

Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am J Physiol Cell Physiol (2003) 2.61

Are second messengers crucial for opening the pore associated with P2X7 receptor? Am J Physiol Cell Physiol (2004) 2.32

Cell-cell communication beyond connexins: the pannexin channels. Physiology (Bethesda) (2006) 2.13

Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol (2003) 1.93

Evolution of gap junction proteins--the pannexin alternative. J Exp Biol (2005) 1.88

N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X(7) receptors. Am J Physiol Cell Physiol (2005) 1.72

Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol (2005) 1.67

Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. J Biol Chem (1991) 1.66

Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol Biol Cell (2003) 1.49

Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem (2005) 1.45

Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am J Physiol Cell Physiol (2003) 1.45

Blockade of human P2X7 receptor function with a monoclonal antibody. Blood (1998) 1.45

Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J Leukoc Biol (1998) 1.45

Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore. Am J Physiol (1999) 1.44

Metabolic regulation of the pancreatic beta-cell ATP-sensitive K+ channel: a pas de deux. Diabetes (2004) 1.30

Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J Neurosci (2003) 1.29

Prospects for rational development of pharmacological gap junction channel blockers. Curr Drug Targets (2002) 1.22

Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells. Br J Pharmacol (2003) 1.13

Kv1.3 potassium channels in human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol (2003) 1.12

Pharmacology of gap junctions in the cardiovascular system. Cardiovasc Res (2004) 1.11

The obligatory link: role of gap junctional communication in endothelium-dependent smooth muscle hyperpolarization. Pharmacol Res (2004) 1.05

Cell-mediated cytotoxicity: ATP as an effector and the role of target cells. Curr Opin Immunol (1991) 1.03

P2Z purinoceptors. Ciba Found Symp (1996) 0.99

Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1 beta post-translational processing. J Immunol (1996) 0.92

Antiapoptotic effect of benzyloxycarbonyl-aspartyl-(beta-tertier-butyl ester)-bromomethylketone (Z-D(OtBu)-Bmk), an intermediate of interleukin-1 beta converting enzyme inhibitors. Int J Immunopharmacol (1997) 0.91

Articles by these authors

Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem (2006) 3.36

P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol (2008) 2.72

Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J Pharmacol Exp Ther (2008) 2.42

Subunit arrangement in P2X receptors. J Neurosci (2003) 1.93

N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X(7) receptors. Am J Physiol Cell Physiol (2005) 1.72

Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J (2009) 1.70

Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol (2005) 1.67

Reanalysis of P2X7 receptor expression in rodent brain. J Neurosci (2004) 1.64

Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol (2009) 1.56

Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem (2005) 1.45

Pharmacological and biophysical properties of the human P2X5 receptor. Mol Pharmacol (2003) 1.44

Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. J Biol Chem (2003) 1.34

Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. J Neurosci (2008) 1.33

The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta release. Purinergic Signal (2009) 1.32

Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Mol Pharmacol (2006) 1.27

P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages. Br J Pharmacol (2003) 1.25

Role of ectodomain lysines in the subunits of the heteromeric P2X2/3 receptor. Mol Pharmacol (2006) 1.24

P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J Immunol (2010) 1.19

Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J Biol Chem (2002) 1.17

Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. J Immunol (2007) 1.12

Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. J Psychiatr Res (2009) 1.10

Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors. Br J Pharmacol (2002) 1.06

Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper. Mol Pharmacol (2007) 1.05

Pannexin 1 forms an anion-selective channel. Pflugers Arch (2012) 1.00

Dynamic regulation of the P2X4 receptor in alveolar macrophages by phagocytosis and classical activation. Eur J Immunol (2009) 1.00

Purinergic P2Y2 receptors induce increased MCP-1/CCL2 synthesis and release from rat alveolar and peritoneal macrophages. J Immunol (2007) 0.97

Sustained depolarization and ADP-ribose activate a common ionic current in rat peritoneal macrophages. J Immunol (2003) 0.93

C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J Biol Chem (2010) 0.88

Interaction between cysteines introduced into each transmembrane domain of the rat P2X2 receptor. Br J Pharmacol (2003) 0.84

Characterization of ATP-gated P2X7 receptors in fish provides new insights into the mechanism of release of the leaderless cytokine interleukin-1 beta. Mol Immunol (2006) 0.83

Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors. Biochem Pharmacol (2007) 0.76